{"2406.00164": {"publish_time": "2024-05-31", "title": "DYNA: Disease-Specific Language Model for Variant Pathogenicity", "paper_summary": "Clinical variant classification of pathogenic versus benign genetic variants\nremains a challenge in clinical genetics. Recently, the proposition of genomic\nfoundation models has improved the generic variant effect prediction (VEP)\naccuracy via weakly-supervised or unsupervised training. However, these VEPs\nare not disease-specific, limiting their adaptation at the point of care. To\naddress this problem, we propose DYNA: Disease-specificity fine-tuning via a\nSiamese neural network broadly applicable to all genomic foundation models for\nmore effective variant effect predictions in disease-specific contexts. We\nevaluate DYNA in two distinct disease-relevant tasks. For coding VEPs, we focus\non various cardiovascular diseases, where gene-disease relationships of\nloss-of-function vs. gain-of-function dictate disease-specific VEP. For\nnon-coding VEPs, we apply DYNA to an essential post-transcriptional regulatory\naxis of RNA splicing, the most common non-coding pathogenic mechanism in\nestablished clinical VEP guidelines. In both cases, DYNA fine-tunes various\npre-trained genomic foundation models on small, rare variant sets. The DYNA\nfine-tuned models show superior performance in the held-out rare variant\ntesting set and are further replicated in large, clinically-relevant variant\nannotations in ClinVAR. Thus, DYNA offers a potent disease-specific variant\neffect prediction method, excelling in intra-gene generalization and\ngeneralization to unseen genetic variants, making it particularly valuable for\ndisease associations and clinical applicability.", "paper_summary_zh": "\u81e8\u5e8a\u907a\u50b3\u5b78\u4e2d\uff0c\u81f4\u75c5\u6027\u907a\u50b3\u8b8a\u7570\u8207\u826f\u6027\u907a\u50b3\u8b8a\u7570\u7684\u81e8\u5e8a\u8b8a\u7570\u5206\u985e\u4ecd\u7136\u662f\u4e00\u9805\u6311\u6230\u3002\u6700\u8fd1\uff0c\u57fa\u56e0\u9ad4\u57fa\u790e\u6a21\u578b\u7684\u63d0\u8b70\u900f\u904e\u5f31\u76e3\u7763\u6216\u7121\u76e3\u7763\u8a13\u7df4\u6539\u5584\u4e86\u901a\u7528\u8b8a\u7570\u6548\u61c9\u9810\u6e2c (VEP) \u7684\u6e96\u78ba\u6027\u3002\u7136\u800c\uff0c\u9019\u4e9b VEP \u6c92\u6709\u75be\u75c5\u7279\u7570\u6027\uff0c\u9650\u5236\u4e86\u5b83\u5011\u5728\u7167\u8b77\u9ede\u7684\u9069\u61c9\u6027\u3002\u70ba\u4e86\u89e3\u6c7a\u9019\u500b\u554f\u984c\uff0c\u6211\u5011\u63d0\u51fa\u4e86 DYNA\uff1a\u900f\u904e Siamese \u795e\u7d93\u7db2\u8def\u9032\u884c\u75be\u75c5\u7279\u7570\u6027\u5fae\u8abf\uff0c\u5ee3\u6cdb\u9069\u7528\u65bc\u6240\u6709\u57fa\u56e0\u9ad4\u57fa\u790e\u6a21\u578b\uff0c\u4ee5\u5728\u75be\u75c5\u7279\u7570\u6027\u80cc\u666f\u4e2d\u9032\u884c\u66f4\u6709\u6548\u7684\u8b8a\u7570\u6548\u61c9\u9810\u6e2c\u3002\u6211\u5011\u5728\u5169\u500b\u4e0d\u540c\u7684\u75be\u75c5\u76f8\u95dc\u4efb\u52d9\u4e2d\u8a55\u4f30 DYNA\u3002\u5c0d\u65bc\u7de8\u78bc VEP\uff0c\u6211\u5011\u5c08\u6ce8\u65bc\u5404\u7a2e\u5fc3\u8840\u7ba1\u75be\u75c5\uff0c\u5176\u4e2d\u81f4\u75c5\u6027\u8207\u529f\u80fd\u7372\u5f97\u4e4b\u9593\u7684\u57fa\u56e0\u75be\u75c5\u95dc\u4fc2\u6c7a\u5b9a\u4e86\u75be\u75c5\u7279\u7570\u6027 VEP\u3002\u5c0d\u65bc\u975e\u7de8\u78bc VEP\uff0c\u6211\u5011\u5c07 DYNA \u61c9\u7528\u65bc RNA \u526a\u63a5\u7684\u57fa\u672c\u8f49\u9304\u5f8c\u8abf\u63a7\u8ef8\uff0c\u9019\u662f\u5df2\u5efa\u7acb\u7684\u81e8\u5e8a VEP \u6307\u5357\u4e2d\u6700\u5e38\u898b\u7684\u975e\u7de8\u78bc\u81f4\u75c5\u6a5f\u5236\u3002\u5728\u5169\u7a2e\u60c5\u6cc1\u4e0b\uff0cDYNA \u90fd\u5fae\u8abf\u4e86\u5404\u7a2e\u9810\u8a13\u7df4\u7684\u57fa\u56e0\u9ad4\u57fa\u790e\u6a21\u578b\uff0c\u91dd\u5c0d\u5c0f\u578b\u3001\u7f55\u898b\u7684\u8b8a\u7570\u7d44\u3002DYNA \u5fae\u8abf\u6a21\u578b\u5728\u4fdd\u7559\u7684\u7f55\u898b\u8b8a\u7570\u6e2c\u8a66\u7d44\u4e2d\u8868\u73fe\u51fa\u512a\u7570\u7684\u6548\u80fd\uff0c\u4e26\u9032\u4e00\u6b65\u8907\u88fd\u65bc ClinVAR \u4e2d\u5927\u578b\u3001\u81e8\u5e8a\u4e0a\u76f8\u95dc\u7684\u8b8a\u7570\u8a3b\u89e3\u3002\u56e0\u6b64\uff0cDYNA \u63d0\u4f9b\u4e86\u4e00\u7a2e\u6709\u6548\u7684\u75be\u75c5\u7279\u7570\u6027\u8b8a\u7570\u6548\u61c9\u9810\u6e2c\u65b9\u6cd5\uff0c\u5728\u57fa\u56e0\u5167\u6982\u5316\u548c\u5c0d\u672a\u898b\u907a\u50b3\u8b8a\u7570\u7684\u6982\u5316\u65b9\u9762\u8868\u73fe\u51fa\u8272\uff0c\u4f7f\u5176\u5c0d\u65bc\u75be\u75c5\u95dc\u806f\u548c\u81e8\u5e8a\u61c9\u7528\u7279\u5225\u6709\u50f9\u503c\u3002", "author": "Huixin Zhan et.al.", "authors": "Huixin Zhan, Zijun Zhang", "id": "2406.00164v1", "paper_url": "http://arxiv.org/abs/2406.00164v1", "repo": "null"}}